Analytical methodologies for discovering and profiling degradation-related impurities

被引:49
作者
Baertschi, Steven W. [1 ]
机构
[1] Eli Lilly & Co, Analyt Sci Res & Dev, Indianapolis, IN 46285 USA
关键词
analytical technology; chemistry-oriented; degradation pathway; degradation product; degradation-related impurity; detector; DRI; forced degradation; impurity; method development; profiling; stability; stability indicating; stress testing; structure elucidation; technique-oriented;
D O I
10.1016/j.trac.2006.05.012
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The analytical technologies currently in use for profiling degradation-related impurities (DRIs) are powerful, but not without their limitations. This article critically assesses the technologies, their strengths and limitations, and recommends strategies for successful DRI profiling. Improvements in analytical separations and detection technologies are leading to strategies involving multiple orthogonal separations and detectors. Advances in knowledge of degradation chemistry and in computer-prediction tools are needed for the future. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:758 / 767
页数:10
相关论文
共 70 条
  • [1] Ahuja S., 2003, HDB ISOLATION CHARAC
  • [2] Ahuja S., 1998, IMPURITIES EVALUATIO
  • [3] The design of a multi-dimensional LC-SPE-NMR system (LC2-SPE-NMR) for complex mixture analysis
    Alexander, AJ
    Xu, F
    Bernard, C
    [J]. MAGNETIC RESONANCE IN CHEMISTRY, 2006, 44 (01) : 1 - 6
  • [4] Alsante K.M., 2003, HDB ISOLATION CHARAC, P361
  • [5] Alsante KM., 2003, Pharma Technol, V27, P60
  • [6] [Anonymous], 2001, PHARM TECHNOL
  • [7] [Anonymous], 1912, PRIX NOBEL 1911, P51
  • [8] Baertschi S. W., 2005, PHARM STRESS TESTING
  • [9] BAERTSCHI SW, 2005, PHARM STRESS TESTING, P4
  • [10] Baertschi SW, 2005, PHARM STRESS TESTING, V153, P181